March 19, 2018 Clinical Research/Diagn. Informatics & Software Life Science Tools PR/Corporate

Human Longevity, Inc. Hires Former Ancestry Executive, Scott Sorensen, As New Chief Technology Officer

INDUSTRY LEADER BRINGS 25 YEARS OF EXPERTISE IN SOFTWARE PRODUCTS AND SERVICES TO HELP HLI SCALE BUSINESS SAN DIEGO, March 19, 2018 /PRNewswire/ — Human Longevity, Inc. (HLI) – the genomics-powered health intelligence company – announced today that Scott Sorensen is joining the leadership team as Chief Technology Officer, reporting to J. Craig Venter, Ph.D., Co-Founder, Chairman and CEO. Sorensen joins... Read more

March 19, 2018 Clinical Research/Diagn. Informatics & Software Life Science Tools PR/Corporate

Luna DNA Expands Leadership and Advisory Board, Adding New Pedigree From Illumina

Three industry leaders join company ranks to drive genomic discovery SAN DIEGO, March 19, 2018 /PRNewswire/ — 9:30 a.m. PT — Luna DNA, the first community owned genomic and medical research database, today announced the addition of three new members to its leadership team. The key hires in the VP of marketing and VP of business strategy and operation... Read more

March 19, 2018 Clinical Research/Diagn. Lab Top-10 Life Science Tools

CMS and Commercial Insurers Extend Coverage of Oncomine Dx Target Test to more than 160 Million U.S. Lives

CMS and Commercial Insurers Extend Coverage of Oncomine Dx Target Test to more than 160 Million U.S. Lives Payors reimburse first NGS, FDA-approved test for non-small cell lung cancer to expedite targeted therapy selection for patients CARLSBAD, Calif., March 19, 2018 /PRNewswire/ — Thermo Fisher Scientific today announced its Oncomine Dx Target Test has been approved for... Read more

March 16, 2018 Forensics & Security Lab Top-10 Life Science Tools M&A, Partnerships

Thermo Fisher Scientific Acquires IntegenX, Provider of Leading Rapid DNA Technology for Human Identification

Thermo Fisher Scientific Acquires IntegenX, Provider of Leading Rapid DNA Technology for Human Identification CARLSBAD, Calif., March 16, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has acquired IntegenX Inc., which provides a rapid DNA platform for use in forensics and law enforcement applications. IntegenX products significantly... Read more

March 15, 2018 Clinical Research/Diagn. Lab Top-10 Life Science Tools M&A, Partnerships

Charité — Universitätsmedizin Berlin Joins Thermo Fisher Scientific’s Next-Generation Sequencing Center of Excellence Program

Charité — Universitätsmedizin Berlin Joins Thermo Fisher Scientific’s Next-Generation Sequencing Center of Excellence Program Leading oncology research hospital becomes new member to advance Oncomine™ liquid biopsy and immuno-oncology diagnostics BERLIN and CARLSBAD, Calif., March 15, 2018 /PRNewswire/ — Thermo Fisher Scientific has named Charité – Universitätsmedizin Berlin as the newest member of its Next Generation Sequencing... Read more

March 13, 2018 Informatics & Software Life Science Tools

Edico Genome Announces Flagship Global Distribution Partnership Program

SAN DIEGO — March 13, 2018 – Edico Genome, the leading secondary analysis solution provider for next-generation sequencing (NGS), today unveiled its DRAGENTM Global Distribution Partner Network, a new program broadening access to its DRAGEN Bio-IT Platform to markets around the world. The Global Distribution Partner Network will provide new and existing DRAGEN customers with regionally focused... Read more

March 13, 2018 Licensing, IP, and Legal Life Science Tools Microscopy

Pacific Biosciences Announces Issuance of U.S. Patent for Concatemer Sequencing

MENLO PARK, Calif., March 13, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that the U.S. Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 9,910,956 (the “956 Patent”), entitled “Sequencing using concatemers of copies of sense and antisense strands.” The 956 Patent was... Read more

March 12, 2018 Lab Top-10 Life Science Tools PR/Corporate

Illumina Names Dr. Phil Febbo Chief Medical Officer

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) announced today the appointment of Dr. Phil Febbo, a leading physician scientist, as Chief Medical Officer (CMO), starting March 26, 2018. In his new role, Dr. Febbo will be responsible for developing and executing on the Company’s medical strategy to drive genomic testing into healthcare practice. “We are very excited to welcome... Read more

March 12, 2018 Life Science Tools M&A, Partnerships Microscopy

QIAGEN and Natera partner to develop cutting-edge genetic testing assays for use on QIAGEN’s GeneReader NGS System

Hilden, Germany, and San Carlos, CA, March 12, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a world leader in providing Sample to Insight molecular solutions, and Natera, Inc. (NASDAQ: NTRA), a leading developer of next-generation sequencing (NGS) assays that include non-invasive prenatal genetic testing and the analysis of circulating tumor DNA, today... Read more